Core Insights - CheqUp and WeightWatchers have formed a partnership to provide a comprehensive weight management solution that combines GLP-1 medication with behavioral support [1][2][3] - The partnership aims to address the increasing demand for effective weight loss solutions in the UK, where 12 million people qualify for GLP-1 medications [3][4] - WeightWatchers' GLP-1 Companion Programme is designed to enhance the effectiveness of weight loss through structured support, showing that participants lose 11% more weight on average when combining medication with behavioral programs [4][6] Company Overview - CheqUp is recognized as a leading provider of medically supervised weight loss programs, offering personalized treatment plans and clinical oversight [9] - WeightWatchers has over 60 years of experience in weight management, utilizing a science-backed model that has helped members achieve significant weight loss results [8][10] Partnership Details - The partnership will provide CheqUp members with access to WeightWatchers' GLP-1 Companion Programme at no additional cost, enhancing their weight loss journey [5][6] - The program includes nutritional guidance, tracking tools, social support networks, and progress monitoring to facilitate sustainable weight loss [7][8]

Summary of Financial Reorganization Plan May 6, 2025 Strategic Action to Eliminate $1.15 Billion of Debt and Strengthen Financial Position The decisive actions we're taking today, with the overwhelming support of our lenders and noteholders, will give us the flexibility to accelerate innovation, reinvest in our members, and lead with authority in a rapidly evolving weight management landscape. As the $1.6B Existing $465M Pro forma ~70% Reduction Debt conversation around weight shifts toward long- term healt ...

About this content About Oliver Haill Oliver has been writing about companies and markets since the early 2000s, cutting his teeth as a financial journalist at Growth Company Investor with a focusing on AIM companies and small caps, before a few years later becoming a section editor and then head of research. He joined Proactive after a couple of years freelancing, where he worked for the Financial Times Group, ITV, Press Association, Reuters sports desk, the London Olympic News Service, Rugby World Cup ...

慧俪轻体公司(WW International Inc.)已申请破产，以实施一项由债权人支持的计划，该计划将从其资产 负债表中削减约11.5亿美元的债务。该公司难以与像奥泽美匹克(Ozempic)这样的减肥药竞争，并且发现 很难让客户相信，在有这些药物的情况下，其减肥项目仍然值得他们投入时间。慧俪轻体报告称，今年 第一季度其收入下降了9.7%，期末订阅用户数量减少了14.2%，净亏损7260万美元。 ...

WW International (WW) came out with a quarterly loss of $0.47 per share versus the Zacks Consensus Estimate of a loss of $0.26. This compares to loss of $0.06 per share a year ago. These figures are adjusted for non- recurring items. This quarterly report represents an earnings surprise of -80.77%. A quarter ago, it was expected that this weight- loss program operator would post a loss of $0.10 per share when it actually produced earnings of $0.32, delivering a surprise of 420%. Over the last four quarters, ...

Summary of Weight Watchers Investor Conference Call (May 06, 2025) Company Overview - **Company**: Weight Watchers International (WW) - **Event**: Investor Conference Call discussing Q1 2025 results and financial reorganization Key Points Financial Reorganization - Weight Watchers has entered a voluntary prepackaged Chapter 11 process to restructure its capital [2][20] - An agreement has been reached with a super majority of lenders to reduce debt by **$1,150,000,000**, a reduction of over **70%** from current levels [6][20] - Long-term debt will decrease from **$1,600,000,000** to **$465,000,000**, with maturities extended to **2030** [6][20] - Anticipated annual interest payments will be halved to approximately **$50,000,000**, improving free cash flow [6][20] - Cash balance at the end of Q1 was **$236,000,000**, including **$171,000,000** from a revolving credit facility drawdown [7][26] Operational Continuity - Weight Watchers remains fully operational during the reorganization, with no impact on services or member plans [9] - All trade creditors and general unsecured creditors will be paid in full [9] Subscriber and Revenue Trends - Total subscribers declined **14%** year-over-year to **3,400,000**, but clinical subscriber growth accelerated by **47%** to **135,000** [21][22] - Q1 revenue was **$187,000,000**, a **10%** decline year-over-year, with clinical revenue growing **57%** to **$29,000,000** [23] - Adjusted gross margin reached a record high of **71%**, up from **67.9%** in the prior year [23] Strategic Focus - The company aims to stabilize and innovate to lay the groundwork for future growth [27] - Weight Watchers emphasizes a holistic approach to weight management, integrating clinical care with behavioral support [12][15] - The company plans to transition clinic members from compounded semaglutide to other medications by May 22, 2025, due to FDA regulations [28] Market Position and Community Engagement - Weight Watchers is recognized as a leader in the weight management industry, with a strong legacy of scientific backing and community support [11][17] - The company highlights the importance of community in achieving weight loss goals, noting that workshop members lose twice as much weight as those who do it alone [17] Future Outlook - Weight Watchers expects continued revenue headwinds in 2025, particularly in the behavioral business, but remains confident in long-term growth potential [29] - The company is focused on operational improvements and disciplined capital allocation to balance profitability with growth [29] Conclusion - Weight Watchers is committed to its transformation and innovation strategy, aiming to emerge from the reorganization as a stronger, publicly traded company [9][20][32]

Operations continue with no impact to its more than three million members worldwide Positions the Company to execute its transformation strategy, focused on enhancing its digital and member experience and expanding its telehealth business which achieved 57% year-over-year revenue growth in Q1 2025 Enters comprehensive agreement with lenders and noteholders to significantly reduce its debt obligations and bolster financial flexibility Expects reorganization plan to be confirmed in approximately 40 days and ...

NEW YORK, May 06, 2025 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ: WW) (“WeightWatchers” or the “Company”), the global leader in science-backed weight management, announced that it will host an investor conference call today May 6, 2025, at 6:00 p.m. ET. During the call, Tara Comonte, President and Chief Executive Officer, and Felicia DellaFortuna, Chief Financial Officer, will discuss an agreement with the Company’s lenders and noteholders that will significantly reduce debt obligations that is cur ...

Exhibit 99.1 WW International, Inc. Announces First Quarter 2025 Results NEW YORK (May 6, 2025) – WW International, Inc. (NASDAQ: WW) ("WeightWatchers," "WW," or the "Company") today announced its results for the first quarter of fiscal 2025 ended March 29, 2025. "We are making progress on our strategic priorities with continued momentum in our Clinical business, while laying the foundation for long-term, sustainable growth," said Tara Comonte, President and CEO. "As the weight management landscape evolves, ...

NEW YORK, May 06, 2025 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ: WW) ("WeightWatchers," "WW," or the "Company") today announced its results for the first quarter of fiscal 2025 ended March 29, 2025. "We are making progress on our strategic priorities with continued momentum in our Clinical business, while laying the foundation for long-term, sustainable growth," said Tara Comonte, President and CEO. "As the weight management landscape evolves, we believe our unique combination of science-backed be ...